Important news: 1. The core PCE price index in the United States recorded an annual rate of 2.9% in August, unchanged from the previous month, in line with market expectations. Stock news: < br...
2025-09-26 13:08:53
< b > Important news: < br > < span class = "section-news" > 1. The U.S. core PCE price index recorded an annual rate of 2.9% in August, unchanged from the previous month, in line with market expectations. < br > < b > Individual stock news: < br > < span class = "section-news" > 1. U.S. regulatory investigation into cryptocurrency strategic reserve company suspected of insider trading. < br > < span class = "section-news" > 2. Intel (INTC. O) has approached TSMC (TSM. N) about investment or manufacturing partnerships. < br > < span class = "section-news" > 3. According to the Wall Street Journal: The U.S. Federal Aviation Administration (FAA) will ease restrictions on the delivery of Boeing (BA. N) aircraft. < br > < span class = "section-news" > 4. MNSO. N proposes to spin off TOP TOY and list it independently on the main board of The Stock Exchange of Hong Kong Limited. < br > < class span = "section-news" > 5. Costco (COST. O) reported fourth-quarter revenue of $86.16 billion, net profit of $2.61 billion, and earnings per share of $5.87. < br > < span class = "section-news" > 6. Raytheon Technologies (RTX. N) has won a contract worth $602 million to provide parts support for the US Navy's F/A-18 fighter jets. < br > < span class = "section-news" > 7. Li Auto (LI. O) 's pure electric i6 has been officially released, with only one configuration in the whole series and a price of 249,800 yuan. The current ideal i6 is set to exceed 20,000 units. < br > < span class = "section-news" > 8. Novartis Pharmaceuticals (NVS. N): Confirmed to invest $23 billion in US infrastructure. The 100% tariffs announced by the US will not affect the company. < br > < span class = "section-news" > 9. Eli Lilly (LLY. N) 's Kisunla (Donanemab) received marketing approval from the European Commission for the treatment of early-stage symptomatic Alzheimer's disease.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
